• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Tamiphosphor monoesters as effective anti-influenz

tetano

Editor, Senior Moderator
Eur J Med Chem. 2014 May 2;81C:106-118. doi: 10.1016/j.ejmech.2014.04.082. [Epub ahead of print]
Tamiphosphor monoesters as effective anti-influenza agents.
Chen CL1, Lin TC1, Wang SY2, Shie JJ2, Tsai KC3, Cheng YS2, Jan JT2, Lin CJ4, Fang JM5, Wong CH6.
Author information
Abstract

Oseltamivir is a potent neuraminidase inhibitor for influenza treatment. By replacing the carboxylate group in oseltamivir with phosphonate monoalkyl ester, a series of tamiphosphor derivatives were synthesized and shown to exhibit high inhibitory activities against influenza viruses. Our molecular modeling experiments revealed that influenza virus neuraminidase contains a 371-cavity near the S1-site to accommodate the alkyl substituents of tamiphosphor monoesters to render appreciable hydrophobic interactions for enhanced affinity. Furthermore, guanidino-tamiphosphor (TPG) monoesters are active to the oseltamivir-resistant mutant. TPG monohexyl ester 4e having a more lipophilic alkyl substituent showed better cell permeability and intestinal absorption than the corresponding monoethyl ester 4c, but both compounds showed similar bioavailability. Intranasal administration of TPG monoesters at low dose greatly improved the survival rate of mice infected with lethal dose of H1N1 influenza virus, whereas 4c provided better protection of the infected mice than oseltamivir and other phosphonate congeners by oral administration.

Copyright ? 2014 Elsevier Masson SAS. All rights reserved.
KEYWORDS:

BQLKEXSYWRBWQK-AFMQGRBTSA-N, Influenza, Inhibitor, Molecular modeling, Neuraminidase, Pharmacokinetics, Virus

PMID:
24836064
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24836064
 
Back
Top Bottom